MDT Medtronic plc
BULLISH
Impact: 1/10
ANALYST-UPGRADE
9 firms acted on MDT: Needham, William Blair, Goldman Sachs, Wolfe Research, Leerink Partners, Citigroup, RBC Capital, UBS, Stifel
Final — all horizons settled through T+60d ⚠ clustered
MDT ▼ -23.80% at T+60d
LONG call ✗ call lost -23.80% · α vs SPY -29.50% · entry $101.62 → $77.44
Last close $80.20 (close Jun 12) · -21.08% from $101.62 entry
T+1d
-0.25%
call -0.25% · α +0.07%
$101.37
settled 4mo ago
T+5d
-5.28%
call -5.28% · α -3.65%
$96.25
settled 4mo ago
T+20d
-11.56%
call -11.56% · α -9.10%
$89.87
settled 3mo ago
T+60d
-23.80%
call -23.80% · α -29.50%
$77.44
settled 6w ago
Price Chart
Loading chart...
Executive Summary
9 firms acted on MDT: Needham, William Blair, Goldman Sachs, Wolfe Research, Leerink Partners, Citigroup, RBC Capital, UBS, Stifel
Impact Score
Base Score
1/7
LLM Adjustment
+0
Final Score
1/10
Consensus & Targets
Buy / Strong Buy
23 (62%)
Hold
13
Sell / Strong Sell
1
Total Analysts
25
Mean PT
$106.56
Median PT
$110.00
High PT
$121.00
Low PT
$84.00
Current Price
$73.81
Implied Upside
+44.4%
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-04-22 | UBS | maintain | Neutral | $90.00 |
| 2026-04-15 | Truist Securities | maintain | Hold | $95.00 |
| 2026-04-13 | Mizuho | maintain | Outperform | $120.00 |
| 2026-04-09 | Evercore ISI Group | maintain | Outperform | $106.00 |
| 2026-04-07 | Citigroup | maintain | Buy | $110.00 |
| 2026-04-06 | Evercore ISI Group | maintain | Outperform | $108.00 |
| 2026-04-06 | Argus Research | maintain | Buy | $115.00 |
| 2026-04-01 | Barclays | maintain | Overweight | $120.00 |
| 2026-04-01 | Piper Sandler | maintain | Neutral | $91.00 |
| 2026-03-26 | Needham | reiterate | Buy | $120.00 |
Firm Track Record — Needham
Needham accuracy: 50% on 4129 calls | avg return: 4.3%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 14 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Mizuho | 100% | 2/2 | 11.1% | top tier |
| Bernstein | 100% | 2/2 | 6.4% | top tier |
| Needham | 75% | 9/12 | 4.1% | top tier |
| Baird | 71% | 5/7 | 4.8% | top tier |
| Citigroup | 67% | 4/6 | 3.5% | top tier |
| UBS | 67% | 4/6 | 4.1% | top tier |
| Wells Fargo | 60% | 3/5 | 3.3% | above average |
| Truist Securities | 60% | 6/10 | 4.8% | above average |
| RBC Capital | 56% | 5/9 | 3% | above average |
| Goldman Sachs | 50% | 1/2 | 4.4% | below average |
Earnings Estimates
Next earnings: Jun 3, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1q | $1.39 | $1.31 — $1.53 | $9.4B | ↑1 ↓0 |
| 0y | $5.53 | $5.50 — $5.64 | $36.1B | ↑1 ↓0 |
| 0q | $1.55 | $1.52 — $1.66 | $9.6B | ↑0 ↓0 |
| +1y | $6.06 | $5.94 — $6.25 | $38.2B | ↑0 ↓0 |
Cross-Platform Signals
Congressional
Kevin Hern (republican) — sell $15,001 - $50,000
Documents Analyzed
Report based on filing metadata.
6 reports for MDT
25%
Hit rate
best @ T+1▲ +4.97%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
10d ago
|
ANALYST-UPGRADE
| $81.91 $81.40 | ▼ −0.62% | ▲ +1.98% | $80.20 (−2.09%) |
|
Jun 3, 2026
11d ago
|
8-K
| $78.03 $81.91 | ▲ +4.97% | ▲ +4.57% | $80.20 (+2.78%) |
|
May 31, 2026
14d ago
|
ANALYST-UPGRADE
| $101.62 $101.37 | ▼ −0.25% | ▲ +0.07% | $80.20 (−21.08%) |
|
May 19, 2026
27d ago
|
Court Ruling
| $78.54 $78.13 | ▼ −0.52% | ▼ −1.56% | $80.20 (+2.12%) |
|
May 1, 2026
6w ago
|
ANALYST-UPGRADE
| $101.62 $101.37 | ▼ −0.25% | ▲ +0.07% | $80.20 (−21.08%) |
|
Apr 6, 2026
10w ago
|
Court Ruling
| $86.25 $86.42 | ▲ +0.20% | ▲ +0.13% | $80.20 (−7.01%) |
Showing 6 of 6
US Market Status
Market Closed — Opens in 3h 56m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access